Virtus Investment Advisers, LLC

Position in PCVX — Vaxcyte, Inc.

CIK 19481 HARTFORD, CT

Position in PCVX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$400,748

+$44,767 QoQ

Shares Held

6,894

+12.5% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#204

of 329 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Virtus Investment Advisers, LLC holds $130,556,170 across 185 Biotechnology names. PCVX ranks #114 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	29,544	$3,349,107
2	ALNY	Alnylam Pharmaceuticals, Inc.	9,953	$2,996,151
3	REGN	Regeneron Pharmaceuticals, Inc.	4,320	$2,693,692
4	MRNA	Moderna, Inc.	23,300	$1,631,699
5	RARE	Ultragenyx Pharmaceutical Inc.	47,757	$1,594,606
6	PGEN	Precigen, Inc.	261,322	$1,489,535
7	AGIO	Agios Pharmaceuticals, Inc.	39,473	$1,464,843
8	RYTM	Rhythm Pharmaceuticals, Inc.	13,158	$1,460,932

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$400,748	6,894	+12.5%	Shares	Other	2026-08-11
2026-03-31	$355,981	6,126	+2.5%	Shares	Other	2026-05-14
2025-12-31	$275,871	5,979	+81.1%	Shares	Other	2026-02-17
2025-09-30	$118,938	3,302	+21.0%	Shares	Other	2025-11-14
2025-06-30	$88,719	2,729	+45.8%	Shares	Other	2025-08-13
2025-03-31	$70,686	1,872	-41.1%	Shares	Other	2025-05-15
2024-03-31	$217,089	3,178	0.0%	Shares	Other	2024-05-16
2023-12-31	$199,578	3,178	0.0%	Shares	Other	2024-02-15
2023-09-30	$162,014	3,178	0.0%	Shares	Other	2023-11-08
2023-06-30	$158,709	3,178	0.0%	Shares	Other	2023-08-14
2023-03-31	$119,111	3,178	-3.3%	Shares	Other	2023-05-15
2022-12-31	$157,611	3,287	—	Shares	Other	2023-02-14
No filing history on record for this holder in this stock.